Log in

OTCMKTS:EMHTF - Emerald Health Therapeutics Stock Price, Forecast & News

-0.01 (-2.19 %)
(As of 12/6/2019 06:59 AM ET)
Today's Range
Now: $0.25
50-Day Range
MA: $0.50
52-Week Range
Now: $0.25
Volume556,067 shs
Average Volume357,212 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Emerald Health Therapeutics, Inc., together with its subsidiaries, produces and sells medical cannabis in Canada. The company was formerly known as T-Bird Pharma Inc. and changed its name to Emerald Health Therapeutics, Inc. in June 2015. Emerald Health Therapeutics, Inc. is headquartered in Victoria, Canada.

Industry, Sector and Symbol

Industry Oil & Gas Production
SectorEnergy Minerals
Phone(800) 757-3536



Sales & Book Value

Annual SalesN/A



Next Earnings DateN/A
OptionableNot Optionable

Receive EMHTF News and Ratings via Email

Sign-up to receive the latest news and ratings for EMHTF and its competitors with MarketBeat's FREE daily newsletter.

Emerald Health Therapeutics (OTCMKTS:EMHTF) Frequently Asked Questions

What is Emerald Health Therapeutics' stock symbol?

Emerald Health Therapeutics trades on the OTCMKTS under the ticker symbol "EMHTF."

What is the consensus analysts' recommendation for Emerald Health Therapeutics?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Emerald Health Therapeutics in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Emerald Health Therapeutics.

Has Emerald Health Therapeutics been receiving favorable news coverage?

News coverage about EMHTF stock has been trending very negative this week, according to InfoTrie. The research group ranks the sentiment of media coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Emerald Health Therapeutics earned a news impact score of -3.0 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 8.0 out of 10, indicating that recent media coverage is very likely to have an effect on the stock's share price in the near term. View News Stories for Emerald Health Therapeutics.

Who are some of Emerald Health Therapeutics' key competitors?

What other stocks do shareholders of Emerald Health Therapeutics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Emerald Health Therapeutics investors own include Canopy Growth (CGC), Charlotte's Web (CWBHF), Aurora Cannabis (ACB), Cronos Group (CRON), KushCo (KSHB), CannaRoyalty (ORHOF), Auxly Cannabis Group (CBWTF), Aurora Cannabis (ACBFF), 22nd Century Group (XXII) and OrganiGram (OGI).

Who are Emerald Health Therapeutics' key executives?

Emerald Health Therapeutics' management team includes the folowing people:
  • Dr. Avtar S. Dhillon, Exec. Chairman & Pres (Age 57)
  • Mr. Robert C. Hill CPA, CPA, CA, CFO & Corp. Sec.
  • Mr. Christopher W. Wagner, Consultant (Age 50)
  • Mr. Michael Bierman, VP of Operations
  • Mr. Allan Rewak, VP of Communications & Stakeholder Relations

How do I buy shares of Emerald Health Therapeutics?

Shares of EMHTF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Emerald Health Therapeutics' stock price today?

One share of EMHTF stock can currently be purchased for approximately $0.25.

What is Emerald Health Therapeutics' official website?

The official website for Emerald Health Therapeutics is http://www.emerald.care/.

How can I contact Emerald Health Therapeutics?

The company can be reached via phone at (800) 757-3536.

MarketBeat Community Rating for Emerald Health Therapeutics (OTCMKTS EMHTF)

Community Ranking:  2.0 out of 5 (star star)
Outperform Votes:  52 (Vote Outperform)
Underperform Votes:  75 (Vote Underperform)
Total Votes:  127
MarketBeat's community ratings are surveys of what our community members think about Emerald Health Therapeutics and other stocks. Vote "Outperform" if you believe EMHTF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe EMHTF will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/6/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel